Showing results (11-20 of 63) with videos related to
Sort By:
Pageof 7
The Review of Scientific Instruments|November 8, 2018
Thin foil proton recoil spectrometer performance study for application in DT plasma measurementsB Marcinkevicius, A Hjalmarsson, E Andersson Sundén, et al.Upsala Journal of Medical Sciences|January 1, 1980
Significance of primary T wave aberrations in the electrocardiogram of asymptomatic young men. Part 1. Electrocardiographic dataJ H Atterhög, L G Ekelund, G Ericsson, et al.Upsala Journal of Medical Sciences|January 1, 1980
Significance of primary T wave aberrations in the electrocardiogram of asymptomatic young men. Part II. Working capacity and anthropometric dataJ H Atterhög, L G Ekelund, G Ericsson, et al.Drugs Under Experimental and Clinical Research|January 1, 1995
Design features of a five-year Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT)U de Faire, C G Ericsson, A Hamsten, et al.Acta Medica Scandinavica|January 1, 1977
The significance of AV block I in asymptomatic young men. Variability, some anthropometric data, orthostatic test reaction and physical work capacityB Ahlborg, J H Atterhög, L G Ekelund, et al.Journal of Dental Research|April 1, 1979
Standard values of the amplitude of jaw jerk action potential and differences due to age, sex and L-dopa treatmentS E Widmalm, H Gill, S Widmalm, et al.European Journal of Pharmacology|November 24, 1992
High concentrations of the neuroleptic remoxipride block voltage-activated Na+ channels in central and peripheral nerve membranesA Westlind-Danielsson, G Ericsson, L Sandell, et al.The Review of Scientific Instruments|November 29, 2014
Determination of hydrogen/deuterium ratio with neutron measurements on MASTI Klimek, M Cecconello, S E Sharapov, et al.The American Journal of Cardiology|November 14, 1997
Effect of bezafibrate treatment over five years on coronary plaques causing 20% to 50% diameter narrowing (The Bezafibrate Coronary Atherosclerosis Intervention Trial [BECAIT])C G Ericsson, J Nilsson, L Grip, et al.Acta Medica Scandinavica|January 1, 1984
Comparative investigation of the antiarrhythmic effect of propafenone (Rytmonorm) and lidocaine in patients with ventricular arrhythmias during acute myocardial infarctionN Rehnqvist, C G Ericsson, S Eriksson, et al.Pageof 7